March 21, 2011

Press Release No. 1

Clarification by Fame India Limited

Significant price movement has been observed in Fame India Limited in the recent past.

The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, had written to the company.

Fame India Limited has vide its letter inter-alia stated, “We wish to inform you that there have been no recent events, announcements or declarations made by Fame India Limited (the Company) that may have a bearing on the operations and / or the performance of the Company including dissemination of any price sensitive information etc."

Press Release No. 2

News about Piramal Healthcare Limited and Piramal Lifesciences Limited

The media had reports on March 19, 2011 that Piramal Healthcare Limited may merge Piramal Life Sciences Limited with itself.

The Exchange, in order to verify the accuracy or otherwise of the information reported in the media and to inform the market place so that the interest of the investors is safeguarded, had written to the companies.

Piramal Healthcare Limited has vide its letter inter-alia stated, "We would like to state that the Company explores various strategic moves from time to time. However, as a policy and in the interest of its shareholders, the Company does not comment on any report relating to potential strategic initiatives unless they have reached the definite stage. We would like to state the Board of Directors of the Company has not considered any proposal for merger of Piramal Life Sciences Limited with the Company."

Piramal Life Sciences Limited has vide its letter inter-alia stated," We would like to state that the Company explores various strategic moves from time to time. However, as a policy and in the interest of its shareholders, the Company does not comment on any report relating to potential strategic initiatives unless they have reached the definite stage. In this context, we would like to inform that the Board of Directors of the Company has not considered any proposal for merger of the Company with Piramal Healthcare Limited. Further, the Company constantly reviews research deals in the ordinary course of business. In the Company's view, there is no such research deal presently being reviewed which is extraordinary. Also, M/s Paramount Pharma Private Limited, a company belonging to the Promoter Group, has vide its letter dated March 11,2011 informed BSE and NSE of its intention to acquire shares of the Company by way of inter-se transfers between and amongst the Promoter group only which would not result in any increase in the overall shareholding of the Promoter Group."

Press Release No. 3

Market-wide Position Limit in VIDEOIND

The derivative contracts in the underlying VIDEOIND have crossed 95% of the market-wide position limit on March 21, 2011. It is hereby informed that all clients/ members shall trade in derivative contracts of VIDEOIND by offsetting their existing positions till the open interest comes down to 80% of the market wide position limit.

Press Release No. 4

NSE completes its 2766^th Normal Settlement

The Exchange has successfully completed its 2766^th Normal Settlement (Rolling T+2 following SEBI directive) since inception i.e., Settlement Number N – 2011052 on Mar 21, 2011. The settlement statistics are as follows:

Particulars	Value
	N-2011052
Total traded quantity (lakhs)	4807.48
Total traded value (Rs. In Crores)	11028.51
Total value of the settlement (Securities) (Rs. In Crores)	2796.18
Total value of the settlement (Funds) (Rs. In Crores)	1055.09
Shortages for the settlement	0.27%
% of Delivery ( No. of shares deliverable / No. of shares traded )	26.43%

Retail Debt Market has completed its 2039^th settlement, details of which are as follows:

Settlement No.	Traded Value	Settlement Value
		Securities	Funds
D- 2011052	NIL	NIL	NIL